These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 36206383)

  • 1. Immunosuppression use in primary antiphospholipid antibody-positive patients: Descriptive analysis of the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository ("Registry").
    Erton ZB; K Leaf R; de Andrade D; Clarke AE; Tektonidou MG; Pengo V; Sciascia S; Ugarte A; Belmont HM; Gerosa M; Fortin PR; Lopez-Pedrera C; Atsumi T; Zhang Z; Cohen H; Ramires de Jesús G; Branch DW; Wahl D; Andreoli L; Rodriguez-Almaraz E; Petri M; Barilaro G; Zuo Y; Artim-Esen B; Willis R; Quintana R; Vendramini MB; Barber MW; Bertolaccini ML; Roubey R; Erkan D
    Lupus; 2022 Dec; 31(14):1770-1776. PubMed ID: 36206383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of Patients With Antiphospholipid Antibody Positivity in the APS ACTION International Clinical Database and Repository.
    Sevim E; Zisa D; Andrade D; Sciascia S; Pengo V; Tektonidou MG; Ugarte A; Gerosa M; Belmont HM; Zamorano MAA; Fortin PR; Ji L; Efthymiou M; Cohen H; Branch DW; de Jesus GR; Andreoli L; Petri M; Rodriguez E; Cervera R; Knight JS; Atsumi T; Willis R; Roubey R; Bertolaccini ML; Erkan D; Barbhaiya M;
    Arthritis Care Res (Hoboken); 2022 Feb; 74(2):324-335. PubMed ID: 32986935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Impact of Systemic Lupus Erythematosus on the Clinical Phenotype of Antiphospholipid Antibody-Positive Patients: Results From the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Clinical Database and Repository.
    Unlu O; Erkan D; Barbhaiya M; Andrade D; Nascimento I; Rosa R; Banzato A; Pengo V; Ugarte A; Gerosa M; Ji L; Efthymiou M; Branch DW; de Jesus GR; Tincani A; Belmont HM; Fortin PR; Petri M; Rodriguez E; Pons-Estel GJ; Knight JS; Atsumi T; Willis R; Zuily S; Tektonidou MG;
    Arthritis Care Res (Hoboken); 2019 Jan; 71(1):134-141. PubMed ID: 29669399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical characteristics of 37 antiphospholipid syndrome patients complicated by autoimmune hemolytic anemia].
    Zhang JT; Qi WT; Zhou YZ; Huang C; Zhao JL; Li MT; Zeng XF
    Zhonghua Nei Ke Za Zhi; 2023 Feb; 62(2):147-155. PubMed ID: 36740405
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical and laboratory characteristics of Brazilian versus non-Brazilian primary antiphospholipid syndrome patients in AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) clinical database and repository.
    de Azevedo Lopes E; Balbi GGM; Tektonidou MG; Pengo V; Sciascia S; Ugarte A; Belmont HM; Gerosa M; Fortin PR; Lopez-Pedrera C; Ji L; Cohen H; de Jesús GR; Branch DW; Nalli C; Petri M; Rodriguez E; Kello N; Ríos-Garcés R; Knight JS; Atsumi T; Willis R; Bertolaccini ML; Erkan D; Andrade D;
    Adv Rheumatol; 2021 Oct; 61(1):64. PubMed ID: 34711275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiphospholipid antibodies and non-thrombotic manifestations of systemic lupus erythematosus.
    İlgen U; Yayla ME; Ateş A; Okatan İE; Yurteri EU; Torgutalp M; Keleşoğlu ABD; Turgay TM; Kınıklı G
    Lupus; 2018 Apr; 27(4):665-669. PubMed ID: 29050535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
    Tektonidou MG; Sotsiou F; Nakopoulou L; Vlachoyiannopoulos PG; Moutsopoulos HM
    Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The comparison of real world and core laboratory antiphospholipid antibody ELISA results from antiphospholipid syndrome alliance for clinical trials & international networking (APS ACTION) clinical database and repository analysis.
    Sciascia S; Willis R; Pengo V; Krilis S; Andrade D; Tektonidou MG; Ugarte A; Chighizola C; Branch DW; Levy RA; Nalli C; Fortin PR; Petri M; Rodriguez E; Rodriguez-Pinto I; Atsumi T; Nascimento I; Rosa R; Banzato A; Erkan D; Cohen H; Efthymiou M; Mackie I; Bertolaccini ML;
    Thromb Res; 2019 Mar; 175():32-36. PubMed ID: 30685523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION): 5-Year Update.
    Barbhaiya M; Andrade D; Erkan D;
    Curr Rheumatol Rep; 2016 Oct; 18(10):64. PubMed ID: 27646150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical thrombotic manifestations in SLE patients with and without antiphospholipid antibodies: a 5-year follow-up.
    Tarr T; Lakos G; Bhattoa HP; Soltesz P; Shoenfeld Y; Szegedi G; Kiss E
    Clin Rev Allergy Immunol; 2007 Apr; 32(2):131-7. PubMed ID: 17916982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with first thrombosis in patients presenting with obstetric antiphospholipid syndrome (APS) in the APS Alliance for Clinical Trials and International Networking Clinical Database and Repository: a retrospective study.
    de Jesús GR; Sciascia S; Andrade D; Barbhaiya M; Tektonidou M; Banzato A; Pengo V; Ji L; Meroni PL; Ugarte A; Cohen H; Branch DW; Andreoli L; Belmont HM; Fortin PR; Petri M; Rodriguez E; Cervera R; Knight JS; Atsumi T; Willis R; Nascimento IS; Rosa R; Erkan D; Levy RA;
    BJOG; 2019 Apr; 126(5):656-661. PubMed ID: 30222236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Damage measured by Damage Index for Antiphospholipid Syndrome (DIAPS) in antiphospholipid antibody-positive patients included in the APS ACTION registry.
    Balbi GGM; Ahmadzadeh Y; Tektonidou MG; Pengo V; Sciascia S; Ugarte A; Belmont HM; Lopez-Pedrera C; Fortin PR; Wahl D; Gerosa M; de Jesús GR; Ji L; Atsumi T; Efthymiou M; Branch DW; Nalli C; Rodriguez Almaraz E; Petri M; Cervera R; Knight JS; Artim-Esen B; Willis R; Bertolaccini ML; Cohen H; Roubey R; Erkan D; de Andrade DCO;
    Rheumatology (Oxford); 2024 Mar; 63(3):772-779. PubMed ID: 37307082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregnancy outcomes in antiphospholipid antibody positive patients: prospective results from the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository ('Registry').
    Erton ZB; Sevim E; de Jesús GR; Cervera R; Ji L; Pengo V; Ugarte A; Andrade D; Andreoli L; Atsumi T; Fortin PR; Gerosa M; Zuo Y; Petri M; Sciascia S; Tektonidou MG; Aguirre-Zamorano MA; Branch DW; Erkan D;
    Lupus Sci Med; 2022 Jun; 9(1):. PubMed ID: 35701043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ophthalmologic manifestations in patients with antiphospholipid antibodies: Beware of iatrogenic complications.
    Menet J; Agrinier N; Dufrost V; Conart JB; Wahl D; Duprez KA; Zuily S
    Lupus; 2021 Oct; 30(11):1799-1807. PubMed ID: 34284674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-bound complement activation products in antiphospholipid antibody-positive patients without other systemic autoimmune rheumatic diseases.
    Erkan D; Vega J; O'Malley T; Concoff A
    Front Immunol; 2024; 15():1459842. PubMed ID: 39355252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
    Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC
    J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiphospholipid antibodies and the risk of autoimmune hemolytic anemia in patients with systemic lupus erythematosus: A systematic review and meta-analysis.
    Bernardoff I; Picq A; Loiseau P; Foret T; Dufrost V; Moulinet T; Unlu O; Erkan D; Wahl D; Zuily S
    Autoimmun Rev; 2022 Jan; 21(1):102913. PubMed ID: 34371159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies.
    Cabiedes J; Cabral AR; Alarcón-Segovia D
    J Rheumatol; 1995 Oct; 22(10):1899-906. PubMed ID: 8991989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics and thrombosis outcomes of paediatric antiphospholipid syndrome: analysis of 58 patients.
    Ma J; Song H; Wei M; He Y
    Clin Rheumatol; 2018 May; 37(5):1295-1303. PubMed ID: 28748509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presence of Immune Complexes of IgG/IgM Bound to B2-glycoprotein I Is Associated With Non-criteria Clinical Manifestations in Patients With Antiphospholipid Syndrome.
    Pérez D; Stojanovich L; Naranjo L; Stanisavljevic N; Bogdanovic G; Serrano M; Serrano A
    Front Immunol; 2018; 9():2644. PubMed ID: 30524428
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.